Former Louisiana congressman Billy Tauzin, who earned himself grumbling from several quarters for his role as the chief lobbyist for the pharmaceutical industry during the Obamacare debate and parted ways with the drug companies two weeks ago, is back in the news today. A report from POLITICO has Tauzin catching on with the high-end DC lobbying firm Alston + Bird, where former Republican senator and 1996 presidential nominee Robert Dole currently plies his trade.
Tauzin’s title will reportedly be “special legislative counsel,” which could mean he’ll be lobbying or providing strategic advice.
“Billy Tauzin continues our record at Alston + Bird for bringing the very best and brightest of legislators to our Washington team, and we and our clients welcome him. He will be a great addition and will complement our full-service practice in Washington,” said Dennis Garris, partner-in-charge of the firm’s Washington office.
Tauzin’s resurfacing didn’t go unnoticed. The Daily Caller noted his new gig in that site’s DC Morning update today…
When you stop by the bar tonight, pour one out for Billy Tauzin: The man responsible for Medicare Part D has finally parted ways with the prescription drug industry. While Tauzin will continue to lobby on behalf of rent-seeking corporations, he’ll no longer be doing it for PhRMA. Last night it was announced that Tauzin will join former Sen. Bob Dole and former Rep. Earl Pomeroy at Alston + Bird. When the news broke that the firm had added another former legislator to its menagerie of back-room deal-brokers, A+P’s Dennis Garris told Politico, “Billy Tauzin continues our record at Alston + Bird for bringing the very best and brightest of legislators to our Washington team, and we and our clients welcome him. He will be a great addition and will complement our full-service practice in Washington.” Tom Daschle, who wants you to know that he is not a lobbyist, also not-lobbied for Alston + Bird.
No word yet on which clients Tauzin will be working with at the firm.